The global glucose biosensors market is likely to exhibit promising growth owing to the rising number of diabetic patients across the globe, says Transparency Market Research (TMR) in a research report. The report is titled, “Glucose Biosensors Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015– 2023.”
The report provides a brief overview of the growth trajectory along with the present situation and future prospects of the global glucose biosensors market. An analysis of the dynamics that are anticipated to impact the growth of the global glucose biosensors market adversely or positively has also been offered in the publication. The study further presents insights into the competitive landscape of the market through Porter’s five forces analysis. It also highlights the products, key marketing strategies, and shares of the leading companies operating in the global glucose biosensors market.
Obtain Report Details @
Biosensors are analytical equipment that converts biological responses into electrical signals and help in gauging a wide range of spectrums such as bacteria, gases, and organic and non-organic compounds. The biosensors comprise biological components that acts as sensors and electrical components use for detecting and transmitting signals. Glucose biosensors are basically employed for detecting the concentration of glucose in patients of diabetes. In order to analyze the glucose amount in individuals, biosensors use proteins, enzymes, and nucleic acids. The two types of glucose sensors available are fluorescence and amprometric glucose biosensors. Amidst these, the most commonly used biosensor is the amprometric glucose biosensor. It is also commercially viable and easily available in the market.
These types of biosensors operate through glucose oxidase. It produces hydrogen peroxide through the oxidation of glucose detected by the electrode, thus analyzing the concentration of the glucose in the body of the patient. Fluorescence biosensors are likely to gain prominence over the forthcoming years owing to innovations in this technology. The market for fluorescence biosensors will be driven by its working life characteristics as it is superior to the working life of amprometric biosensor. Factors such as growing practice of glucose biosensors in non-medical applications and rise in demand for point of care and home care diagnostics are further anticipated to boost the growth of the market.
Region-wise, the market is dominated by North America at present owing to the rising number of diabetic patients in the region and ongoing technological advancements. The market for glucose biosensors will also witness prominent growth in Europe due to the high efficiency of biosensors and mounting aging population. The players in the market are M-Biotech Limited, F. Hoffman-La Roche, LifeScan Inc., Siemens Healthcare Diagnostics Inc., Nova Biomedical Corp., and Abbott Point Of Care Inc. among others.
Fill the form for an exclusive sample of this report @
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.